Minerva Neurosciences Inc

General ticker "NERV" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $16.8M

Minerva Neurosciences Inc does not follow the US Stock Market performance with the rate: -28.3%.

Estimated limits based on current volatility of 2.6%: low 2.12$, high 2.23$

Factors to consider:

  • Current price 50.0% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [4.24$, 11.37$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.45$, 7.11$]

Financial Metrics affecting the NERV estimates:

  • Negative: Non-GAAP EPS, $ of -4.65 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -26.36 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term NERV quotes

Long-term NERV plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $45.37MM $25.23MM $23.12MM
Operating Income $-45.37MM $-25.23MM $-23.12MM
Non-Operating Income $-6.34MM $-6.88MM $-6.89MM
Interest Expense $6.33MM $7.41MM $8.28MM
R&D Expense $32.04MM $14.65MM $12.71MM
Income(Loss) $-51.71MM $-32.11MM $-30.01MM
Taxes $-1.80MM $0.00MM $0.00MM
Profit(Loss) $-49.91MM $-32.11MM $-30.01MM
Stockholders Equity $7.98MM $-20.02MM $-28.46MM
Inventory $0.00MM $3.02MM $0.00MM
Assets $77.12MM $55.09MM $56.90MM
Operating Cash Flow $-24.60MM $-24.65MM $-14.78MM
Capital expenditure $0.00MM $0.02MM $0.00MM
Investing Cash Flow $0.00MM $-0.02MM $0.00MM
Financing Cash Flow $60.00MM $-0.00MM $19.60MM
Earnings Per Share* $-9.35 $-7.30 $-4.61

* EPS are Split Adjusted, recent splits may be reflected with a delay.